ArticleScientific reports2025

Comparative analysis of bevacizumab and sorafenib on the survival of retinal ganglion cells in the treatment of retinal diseases.

Wungrak Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.